BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
63 results:

  • 1. pancreaticoduodenectomy in patients with an unusual course of the hepatic artery.
    Skalický P; Loveček M; Tesaříková J; Gregořík M; Knápková K; Kovář R; Klos D
    Rozhl Chir; 2023; 102(3):111-118. PubMed ID: 37344204
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study.
    Eder P; Verstock B; Culver E; Dragoni G; Kredel LI; Wypych J; de Paredes AGG; Kaniewska M; Leibovitzh H; Lobaton T; Truyens M; Oracz G; Ribaldone DG; Starzyńska T; Badaoui A; Rahier JF; Bezzio C; Bossuyt P; Falloon K; Pugliese D; Frakes Vozzo C; Jess T; Larsen L; Olesen SS; Pal P; Chaparro M; Dror D; Ellul P; Gromny I; Janiak M; Maciejewska K; Peleg N; Bar-Gil Shitrit A; Szwed Ł; Talar-Wojnarowska R; Snir Y; Weisshof R; Zittan E; Miechowicz I; Goren I
    J Crohns Colitis; 2023 Nov; 17(11):1791-1799. PubMed ID: 37283545
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Recent Development of Supramolecular cancer Theranostics Based on Cyclodextrins: A Review.
    Hu W; Ye B; Yu G; Huang F; Mao Z; Ding Y; Wang W
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110674
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pancreatic adenocarcinoma: A retrospective single-centre observational study.
    Brugel M; Dupont M; Carlier C; Botsen D; Essi DE; Sanchez V; Slimano F; Perrier M; Bouché O
    Pancreatology; 2023 Jun; 23(4):403-410. PubMed ID: 37037682
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A case report of anterior mediastinal signet ring cell carcinoma.
    Liu S; Zhao A; Mao M
    Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Targeting Tumor Microenvironment in Liver cancers: Rationale, Current Progress, and Future Perspective.
    Duda DG
    Keio J Med; 2022; 71(3):71. PubMed ID: 36155490
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
    Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
    Front Immunol; 2022; 13():923031. PubMed ID: 35924241
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Castleman Disease Misdiagnosed as pancreatic Neuroendocrine Tumor by Fine Needle Aspiration Biopsy.
    Gou H; Fan J; Luo M; Liu S; Yang X; He K
    Am Surg; 2023 Jun; 89(6):2979-2981. PubMed ID: 35544955
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic biomarkers related to tumoral microenvironment in pancreatic ductal adenocarcinoma: a systematic review.
    Constantin AL; Cazacu IM; Stroescu C; Copăescu C; Săftoiu A
    Rom J Morphol Embryol; 2021; 62(3):671-678. PubMed ID: 35263394
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target.
    Xu JL; Guo Y
    Invest New Drugs; 2022 Feb; 40(1):58-67. PubMed ID: 34515878
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With cancer.
    Jacob JS; Dutra BE; Garcia-Rodriguez V; Panneerselvam K; Abraham FO; Zou F; Ma W; Grivas P; Thompson JA; Altan M; Oliva ICG; Zhang HC; Thomas AS; Wang Y
    J Natl Compr Canc Netw; 2021 Aug; 19(12):1415-1424. PubMed ID: 34348238
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Castleman's disease masquerading as pancreatic neuroendocrine tumour.
    Gunda D; Naughton J; Stevens SG; Perini MV
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34167983
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. cancer Risk in 47,241 Individuals With Celiac Disease: A Nationwide Cohort Study.
    Lebwohl B; Green PHR; Emilsson L; Mårild K; Söderling J; Roelstraete B; Ludvigsson JF
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e111-e131. PubMed ID: 34033925
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tissue diagnosis Is Associated With Worse Survival in Hepatocellular Carcinoma: A National cancer Database Analysis.
    Dahdaleh FS; Naffouje SA; Sherman SK; Kamarajah SK; Salti GI
    Am Surg; 2022 Jun; 88(6):1234-1243. PubMed ID: 33830824
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for gastrointestinal cancer immunotherapy.
    Zhang H; Li M; Kaboli PJ; Ji H; Du F; Wu X; Zhao Y; Shen J; Wan L; Yi T; Wen Q; Li X; Cho CH; Li J; Xiao Z
    Int J Biol Markers; 2021 Jun; 36(2):22-32. PubMed ID: 33788641
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma.
    Park Y; Jun HR; Choi HW; Hwang DW; Lee JH; Song KB; Lee W; Kwon J; Ha SH; Jun E; Kim SC
    Sci Rep; 2021 Jan; 11(1):1644. PubMed ID: 33462311
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Thymic Carcinoid as the First Manifestation of Multiple Endocrine Neoplasia Type 1 Syndrome: A Case Report and Review of the Literature.
    Zheng M; Chen S; Qi C; Ren L; Zhen Y; Yu X; Wei L
    Ann Clin Lab Sci; 2020 Nov; 50(6):825-833. PubMed ID: 33334800
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in pancreatic Ductal Adenocarcinoma.
    Herlea V; Mustafa ES; Iorgescu AC; Pechianu NC; Cretoiu D; Sajin M; Dima SO; Vasilescu C; Stroescu C; Ungureanu C; Dumitrascu T; Brasoveanu V; Ghinescu M; Popescu I
    J Immunol Res; 2020; 2020():6148286. PubMed ID: 33062723
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.
    Nevi L; Di Matteo S; Carpino G; Zizzari IG; Samira S; Ambrosino V; Costantini D; Overi D; Giancotti A; Monti M; Bosco D; De Peppo V; Oddi A; De Rose AM; Melandro F; Bragazzi MC; Faccioli J; Massironi S; Grazi GL; Panici PB; Berloco PB; Giuliante F; Cardinale V; Invernizzi P; Caretti G; Gaudio E; Alvaro D
    Hepatology; 2021 Jan; 73(1):144-159. PubMed ID: 32978808
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. diagnosis of pancreatic solid pseudopapillary neoplasms using cell-blocks and immunohistochemical evaluation of endoscopic ultrasound-guided fine needle aspiration biopsy specimens.
    Ardengh JC; Lopes CV; Venco FE; Machado MA
    Cytopathology; 2021 Jan; 32(1):50-56. PubMed ID: 32816310
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.